Preferred Drug List

Preferred Drug List A. The Division of Medicaid recommends that prescribers use the drugs on the Preferred Drug List (PDL). 1. The PDL is defined as a list of drugs reviewed and proposed by the Pharmacy and Therapeutics (P&T) Committee, a group of physicians, pharmacists, nurse practitioners, and/or other health care professionals. Final approval of the PDL is the responsibility of the Executive Director of the Division of Medicaid. 2. The PDL contains a wide range of generic and preferred brand name products approved by the FDA. 3. A medication becomes a preferred drug based first on safety and efficacy, then on cost- effectiveness. B. Prior authorizations for non-preferred drugs may be approved for medically accepted indications when criteria have been met. C. Drugs must be prescribed and dispensed in accordance with medically accepted indications for uses and dosages. No payment will be made under the Medicaid program for services, procedures, supplies or drugs still in clinical trials and/or investigative or experimental in nature. D. Prior authorizations are reviewed and a determination notice provided within twenty-four (24) hours from receipt of request. If a PA is not available, a seventy-two (72) hour emergency supply must be dispensed. Pharmacists should use his/her professional judgment regarding whether or not there is an immediate need every time the seventy-two (72) hour option is used. The seventy-two (72) hour emergency procedure must not be used for routine and continuous overrides. E. The PDL is subject to change. [Refer to the Division of Medicaid’s website for a current listing of prescription drugs on the PDL.]